Latest Breaking News On - Massimo giachetti - Page 1 : comparemela.com

Pfizer: Too Cheap To Miss Out (NYSE:PFE)

Pfizer trades below pre-pandemic levels despite a major new acquisition, a promising pipeline, and a 5.7% dividend yield. See why PFE stock is a Buy.

United statesNew yorkAlbert bourlaPfizerMassimo giachettiStrong buy

Things Are Going To Get Very Ugly For AMC Entertainment Holdings (NYSE:AMC)

Things Are Going To Get Very Ugly For AMC Entertainment Holdings (NYSE:AMC)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMassimo giachettiGamestopBox office authorEntertainment holdingsBox officeTwitterRoaring kitty

AMC cashes in on meme rally with $250M stock offering; shares +246% in two days (NYSE:AMC)

AMC cashes in on meme rally with $250M stock offering; shares +246% in two days (NYSE:AMC)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMassimo giachettiGamestopStock editorialBill maurer

AMC stock sinks after theatre chain warns of weaker second-quarter (NYSE:AMC)

AMC stock sinks after theatre chain warns of weaker second-quarter (NYSE:AMC)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMassimo giachettiAdam aronBillie eilishTaylor swiftStock editorial

Pfizer Stock: Finally The Market Is Waking Up (NYSE:PFE)

Pfizer Stock: Finally The Market Is Waking Up (NYSE:PFE)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMassimo giachettiArgus researchPfizerBristol myers squibbPfizer incSeeking alphaWall street